Magazine Article | July 1, 2015

Regeneron: A Biotech With Commercial Confidence From The First Compound

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma
Follow Me On Twitter @Louis_Garguilo

In 2001, members of a small biotech from the New York City area traveled to the state capital, Albany, to discuss accessing the state’s new Biotechnology Industry Growth Fund. An economic development official responsible for a portion of that fund met with them but came away skeptical.

Biotech was still a new industry; this company had failed in the clinic and was just getting new compounds into development. Its self-assuredness seemed misplaced. “When would NY residents see any return on investment?” asked the stern official. “How many jobs will your start-up create?